Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

16. REFERENCES
16 REFERENCES
AHQ [1989]. Guide de gestion des déchets comportant des risques en milieu hospitalier, 72 pages + appendices.
APES [2003]. Recueil d’informations pharmaceutiques en oncologie, October, 284 pages. [Web site accessed on
October 18, 2007: http://www.apesquebec.org/membres/comites/ronc/GuideFr/GuideComplet200310.pdf].
ASHP [2006]. “Guidelines on handling hazardous drugs”, Am J Health-System Pharm, Vol. 63, June 15, p. 1172-1191.
ASHP [2007]. “ASHP Final Comments to NIOSH Regarding the Definition of Hazardous Drugs”, September 20, 2007,
16 pages. [Web site accessed on September 24, 2007:
http://www.ashp.org/s_ashp/docs/files/Hazardous_Drugs_Comments_Final.pdf].
Au C, Jorgenson J, Smith B [2006]. Evaluation of Vial Transfer Devices for Containment of Hazardous Drug Vapors,
presented at UHC Resident Poster Session, ASHP Mid Year Clinical Meeting, December 3-7, Anaheim, CA.
Boothroyd L. and P. Lehoux [2004]. La chimiothérapie basée au domicile. Les enjeux pour les patients, les soignants et
le réseau de la santé, Agence d’évaluation des technologies et des modes d’intervention en santé, Government of
Quebec, Montreal, May, 92 pages.
Blecher, C. S., E. M. Glynn-Tucker, M. McDiarmid, S. A. Newton [2003]. Oncology nursing society: Safe Handling of
hazardous drugs, Oncology Nursing Society, 2003, 55 pages.
Buchanan, E.C., P.J. Schneider [2005]. Compounding sterile preparations, 2nd Ed., ASHP, 2005, 350 pages.
Bussières JF, K. Gagnon, G. Bérard, C. Gallant, P. Barret [2006a]. “Une enquête dans les pharmacies du Québec”,
Objectif prévention, Vol. 29, No. 5, p. 13 – 14. [http://www.asstsas.qc.ca/documentation/op/op295013.pdf].
Bussières, J. F., M. Lefebvre, C. Gallant, S. Prot-Labarthe, L. Lefebvre [2006b]. “Interprétation des niveaux de
contamination en médicaments dangereux”, Bulletin d’information toxicologique, INSPQ, Vol. 22, No. 2, p. 17-24.
Bussières JF, K. Gagnon, G. Bérard, C. Gallant, P. Barret [2007].”Enquête québécoise sur la preparation et
l’administration de medicaments dangereux incluant les médicaments cytotoxiques”, Pharmactuel, Vol. 40, No. 1,
January-February 2007, p. 37 – 42. [www.pharmactuel.com].
Connor TH, Anderson RW, Sessink PJM, et al. [1999]. “Surface contamination with antineoplastic agents in six cancer
treatment centers in Canada and the United States”, Am J Health-System Pharm., 56:1427-32.
Connor TH, Anderson RW, Sessink PJM, Spivey S. [2002]. “Effectiveness of a closed-system device in containing
surface contamination with cyclophosphamide and ifosfamide in an IV admixture area”, Amer J Health-System Pharm,
Vol. 59, p. 68-72.
Connor TH, MA McDiarmid [2006]. “Preventing occupational exposures to antineoplastic drugs in health-care
settings”, CA Cancer J Clin, Vol. 56, p. 354-365.
Connor TH, Sessink PMJ, Harrison BR et al [2005]. “Surface contamination of chemotherapy drug vials and evaluation
of new vial-cleaning techniques: result of three studies”, Am J Health-Syst Pharm, 62:475-84.
Connor TH, M. Shults, MP Fraser [2000]. “Determination of the vaporization of solutions of mutagenic agents at 23
and 37 degrees C using a dessicator technique”, Mutat Res, Vol. 470, p. 85-92.
CSA [2002]. Handling of Waste Materials in Health Care Facilities and Veterinary Health Care Facilities, (National
Standard of Canada, approved in February 2003), CAN/CSA/Z31.10-01, 32 pages.
CSHP [1997]. Guidelines for the handling and disposal of hazardous pharmaceuticals (including cytotoxic drugs),
1997. 12 pages. www.cshp.ca
Dranitsaris G, Johnston M, Poirier S, Schueller T, Milliken D, Green E, Zanke B. [2005]. "Are health care providers
who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the
literature", J Oncol Pharm Pract. Jun;11(2):69-78.
Ensslin AS, Stoll Y, Pethran A,Pfaller A, Rommelt H, Fruhmann G [1994]. “Biological monitoring of
cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs”, Occup
Environ Med, 51(4):229-33.
Favier B. et al. [2003]. “External contamination of vials containing cytotoxic agents by pharmaceuticals
manufacturers”, J Oncol Pharm Practice, Vol. 9, p. 15 – 20.
Favier B. et al. [2004]. “Médicaments cytotoxiques : évaluation de l’impact de la purge des lignes de perfusion sur
l’exposition du personnel infirmier”, Archiv Mal Prof, Vol. 65, No. 1, p. 9-17.
PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS ASSTSAS 16-1